Articles
| Open Access |
https://doi.org/10.55640/
CHARACTERISTICS OF HEMOGRAM AND BIOCHEMICAL BLOOD MARKERS IN PATIENTS WITH POST-COVID AND DERMATOLOGICAL SYNDROMES
Ergashev Z.A., Nuralieva D.M. , Military Medical Academy of the Armed Forces of the Republic of UzbekistanAbstract
This article is dedicated to the study of hemogram characteristics and biochemical blood markers in patients with post-COVID and dermatological syndromes. Changes in blood composition are analyzed, such as leukocyte and platelet levels, as well as markers reflecting inflammatory processes, including C-reactive protein, fibrinogen, and cytokines. Special attention is given to identifying correlations between changes in these markers and manifestations of skin diseases observed in patients who have recovered from COVID-19. The results of this study may serve as a basis for the development of new diagnostic and monitoring methods for patients with dermatological and post-COVID manifestations, as well as optimizing therapy taking into account changes in biochemical blood markers.
Keywords
post-COVID dermatitis, military personnel, systemic inflammatory response syndrome (SIRS), alanine aminotransferase (ALT) and aspartate aminotransferase (AST) COVID-19, SARS-CoV-2, Post-COVID Syndrome (PCS).
References
Magro C, Mulvey JJ, et al. Complement-associated microvascular injury and thrombosis in severe COVID-19. Transl Res. 2020.
Ackermann M, Verleden SE, et al. Pulmonary vascular endothelialitis and angiogenesis. N Engl J Med. 2020.
Gupta A, Madhavan MV, et al. Extrapulmonary manifestations of COVID-19. Nat Med. 2020.
Perico L, Benigni A, et al. Immunothrombosis in COVID-19. Nat Rev Nephrol. 2021.
Libby P, Lüscher T. COVID-19 is, in the end, an endothelial disease. Eur Heart J. 2020.
Goshua G, Pine AB, et al. Endotheliopathy in COVID-19. Lancet [17] Haematol. 2020.
Rovas A, Osiaevi I, et al. Microvascular alterations in severe COVID-19. Crit Care. 2021.
Merrill JT, et al. Complement as a target in COVID-19. Lancet [17] Rheumatol. 2020.
E. Иммунология и биомаркеры (в т.ч. long-COVID)
Blanco-Melo D, Nilsson-Payant BE, et al. Imbalanced host response to SARS-CoV-2. Cell. 2020.
Sette A, Crotty S. Adaptive immunity to SARS-CoV-2. Cell. 2021.
Phetsouphanh C, Darley DR, et al. Immunological dysfunction persists for 8 months. Nat Immunol. 2022.
Peluso MJ, Deeks SG, et al. Immune correlates of Long-COVID. Clin Infect Dis. 2022/2023.
Townsend L, Dyer AH, et al. Persistent fatigue after COVID-19 and immune markers. PLoS One. 2020.
Article Statistics
Downloads
Copyright License
This work is licensed under a Creative Commons Attribution 4.0 International License.